AAPP President-Elect Michelle Geier, PharmD, BCPP, has been working with others on local legislation in San Francisco to require pharmacies to stock buprenorphine. Legislation was recently introduced that aims to align California law with federal regulations to reduce barriers to treatment for opioid use disorder. Learn more.